Atea Pharmaceuticals, Inc. (AVIR)
4.59
-0.06
(-1.29%)
USD |
NASDAQ |
Feb 23, 16:00
4.605
+0.02
(+0.33%)
After-Hours: 19:59
Atea Pharmaceuticals SG&A Expense (Quarterly) : 7.22M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 1.274M |
| Aclaris Therapeutics, Inc. | 4.871M |
| PMV Pharmaceuticals, Inc. | 4.312M |
| Instil Bio, Inc. | 5.895M |
| Coya Therapeutics, Inc. | 2.557M |